Diagnostic News and Research

RSS
Abbott seeks U.S. approval for HE4 assay to monitor recurrence/progression of epithelial ovarian cancer

Abbott seeks U.S. approval for HE4 assay to monitor recurrence/progression of epithelial ovarian cancer

QIAGEN acquires global licence for PI3K gene to develop real-time-PCR and endpoint PCR assays

QIAGEN acquires global licence for PI3K gene to develop real-time-PCR and endpoint PCR assays

Third-quarter fiscal 2010 results announced by Chindex International

Third-quarter fiscal 2010 results announced by Chindex International

Increased Medicare reimbursement leads to rise in outpatient bladder cancer surgeries

Increased Medicare reimbursement leads to rise in outpatient bladder cancer surgeries

Quest Diagnostics to reaffirm 2010 guidance at the UBS 2010 Global Healthcare Services Conference

Quest Diagnostics to reaffirm 2010 guidance at the UBS 2010 Global Healthcare Services Conference

HPV vaccination programs may reduce genital diseases

HPV vaccination programs may reduce genital diseases

HDC partners with New York surgery center to develop new molecular diagnostic tests for pancreatic cancer

HDC partners with New York surgery center to develop new molecular diagnostic tests for pancreatic cancer

AMAG Pharmaceuticals releases safety update on Feraheme Injection

AMAG Pharmaceuticals releases safety update on Feraheme Injection

BIO urges HHS to preserve incentives for investment and innovation; improve patient access to genetic tests

BIO urges HHS to preserve incentives for investment and innovation; improve patient access to genetic tests

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

Nearly 50% of essential services provided for cancer treatment not reimbursed by Medicare

Nearly 50% of essential services provided for cancer treatment not reimbursed by Medicare

Non-invasive MR Spectroscopy to determine ability to be fathers

Non-invasive MR Spectroscopy to determine ability to be fathers

FDA awards highest quality rating for Carol Milgard Breast Center

FDA awards highest quality rating for Carol Milgard Breast Center

Tecan Group, Enigma Diagnostics sign manufacturing and supply agreement for Enigma ML instruments

Tecan Group, Enigma Diagnostics sign manufacturing and supply agreement for Enigma ML instruments

ARUP Laboratories adds three downstream cost calculators to its Suite of Utilization Management Services

ARUP Laboratories adds three downstream cost calculators to its Suite of Utilization Management Services

St. Jude Medical receives European approval for Fortify ST ICD and Unify CRT-D defibrillators

St. Jude Medical receives European approval for Fortify ST ICD and Unify CRT-D defibrillators

Arrayit's VIP DNA testing technology receives patent protection in Israel

Arrayit's VIP DNA testing technology receives patent protection in Israel

Pfizer, DxS sign agreement to develop a diagnostic test kit for CDX-110 to treat patients with GBM

Pfizer, DxS sign agreement to develop a diagnostic test kit for CDX-110 to treat patients with GBM

Toshiba America Medical Systems' Viamo laptop ultrasound system receives FDA clearance

Toshiba America Medical Systems' Viamo laptop ultrasound system receives FDA clearance

Neuroscience research and clinical care launched at UT Medical School

Neuroscience research and clinical care launched at UT Medical School

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.